SCHEMBL375144

SCHEMBL375144

Clc1cc(Cl)cc(CNC2CCOCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
KDM1A O60341 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.41
OPRL1 P41146 6/20 0.40
ALDH1A1 P00352 2/20 0.40
EPAS1 Q99814 1/20 0.40
TSHR P16473 1/20 0.40
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
MAP4K4 O95819 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
BACE1 P56817 1/20 0.38
SLC2A1 P11166 1/20 0.38
KDM4E B2RXH2 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375076 0.83 CARM1 (0.56) POLBMEN1KMT2AMAPK1OPRL1
SCHEMBL375623 0.82 BCHE (0.46) POLBMEN1KMT2AOPRL1ALDH1A1
SCHEMBL26268982 0.81 POLB (0.62) POLBKDM1AMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL31567098 0.80 POLB (0.66) POLBKDM1AMEN1KMT2AALDH1A1
SCHEMBL375410 0.79 POLB (0.47) POLBMAPK1OPRL1TSHROPRM1
SCHEMBL375074 0.79 POLB (0.47) POLBMAPK1OPRL1ALDH1A1EPAS1
SCHEMBL1518347 0.79 POLB (0.46) POLBKDM1AMEN1KMT2AALDH1A1
SCHEMBL375105 0.75 KDM1A (0.48) POLBKDM1AMEN1KMT2AOPRL1
SCHEMBL375264 0.74 GRIN2B (0.62) MEN1KMT2AOPRL1CARM1PRMT6
SCHEMBL5760854 0.72 KCNH2 (0.46) POLBKDM1AALDH1A1TSHRCARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 POLB 3019/4885KDM1A 4445/4885MEN1 2688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.